Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Inflammatory Myofibroblastic Tumor: A Case Report of Neoadjuvant Alectinib and Summary of Single-Institution Molecular Data.
Journal: JCO precision oncology
Published: June 08, 2026
Impact of Genomic Subtype on Intracranial Outcomes in Treatment-naive EGFR mutant NSCLC with Osimertinib (IGnITE).
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 17, 2026
Exploring healthcare providers' perceptions of virtual reality in lung cancer treatment preparedness: a mixed-methods feasibility study for the development of EveryBreathMatters.
Journal: Scientific reports
Published: August 20, 2025
Systematic review on the technology's role in supporting lung cancer patients in the treatment journey.
Journal: NPJ digital medicine
Published: March 21, 2025
First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study.
Journal: The Lancet. Oncology
Published: February 28, 2025
Central Nervous System Metastases from Primary Lung Carcinoma: Significance of RNA Fusion Testing and Early Versus Late Metastases.
Journal: Journal of personalized medicine
Published: February 25, 2025
Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From EGFR and ALK Oncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 24, 2024
Unusual presentation of ROS1 rearranged metastatic non-small cell lung cancer.
Journal: Respiratory medicine case reports
Published: May 08, 2024
Weight loss in patients on osimertinib for metastatic EGFR-mutant non-small cell lung cancer.
Journal: The oncologist
Published: February 12, 2024
Chemotherapy and Osimertinib Combination Should Be the First-Line Treatment for All Advanced EGFR+ NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 12, 2023
Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA).
Journal: Pigment cell & melanoma research
Published: July 06, 2023
Considerations for adjuvant immunotherapy in stage II melanoma: KEYNOTE-716 and beyond.
Journal: Annals of translational medicine
Published: February 27, 2023
Last Updated: 09/26/2026